Oruka Therapeutics announced that it will receive $275 million in a round of funding on April 3, 2024. The transaction included participation from syndicate of healthcare investors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.6 USD | +3.72% |
|
+10.43% | +111.76% |
04-25 | ARCA biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-19 | North American Morning Briefing : Stock Futures -2- | DJ |
1st Jan change | Capi. | |
---|---|---|
+111.76% | 52.23M | |
+16.13% | 122B | |
+19.65% | 113B | |
+21.22% | 26.49B | |
-23.84% | 19.4B | |
-17.47% | 16.24B | |
-45.95% | 15.15B | |
-19.28% | 15.4B | |
+63.81% | 14.93B | |
+1.94% | 13.52B |
- Stock Market
- Equities
- ABIO Stock
- News ARCA biopharma, Inc.
- Oruka Therapeutics announced that it expects to receive $275 million in funding